Torben Nissen
Chief Executive Officer bei Repertoire Immune Medicines, Inc.
Vermögen: - $ am 31.12.2023
Profil
Torben Straight Lauesgaard Nissen is currently the Chief Executive Officer at Repertoire Immune Medicines, Inc. and a Senior Partner at Flagship Pioneering.
Previously, he held positions such as Managing Director at Maxygen, Inc., Chief Operating Officer & Executive Director at Centers for Therapeutic Innovation, Independent Director at Axcella Health, Inc., Director at Ring Therapeutics, Inc., Head-Worldwide Research & Development at Pfizer Inc., Principal at Novo Nordisk A, President at moksha8 Pharmaceuticals, Inc., and Chief Operating Officer at Ascendis Pharma A.
He also served as President at Rubius Therapeutics, Inc. Dr. Nissen obtained his graduate and doctorate degrees from the Technical University of Denmark.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AXCELLA HEALTH, INC.
-.--% | 31.10.2023 | 0 ( -.--% ) | - $ | 31.12.2023 |
Aktive Positionen von Torben Nissen
| Unternehmen | Position | Beginn |
|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Chief Executive Officer | 06.11.2022 |
Ehemalige bekannte Positionen von Torben Nissen
| Unternehmen | Position | Ende |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 01.11.2023 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | 01.12.2021 |
| RUBIUS THERAPEUTICS | President | 24.07.2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01.11.2016 |
| Centers for Therapeutic Innovation | Chief Operating Officer | 01.01.2014 |
Ausbildung von Torben Nissen
| Technical University of Denmark | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| AXCA HEALPAR | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Health Technology |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Centers for Therapeutic Innovation | |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
